Evaluating therapeutic benefits of ubrogepant via latent class models: A post hoc exploratory analysis of the ACHIEVE I and ACHIEVE II trials
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluating therapeutic benefits of ubrogepant via latent class models: A post hoc exploratory analysis of the ACHIEVE I and ACHIEVE II trials
Authors
Keywords
-
Journal
HEADACHE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-10-24
DOI
10.1111/head.14631
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II randomized trials
- (2022) Richard B. Lipton et al. JOURNAL OF HEADACHE AND PAIN
- Systematic review of outcomes and endpoints in acute migraine clinical trials
- (2021) Carrie R. Houts et al. HEADACHE
- Measuring headache day severity using multiple features in daily diary designs
- (2021) James S McGinley et al. CEPHALALGIA
- A close association of freedom from pain, migraine-related functional disability, and other outcomes: results of a post hoc analysis of randomized lasmiditan studies SAMURAI and SPARTAN
- (2021) Richard B. Lipton et al. JOURNAL OF HEADACHE AND PAIN
- Ubrogepant, an Acute Treatment for Migraine, Improved Patient‐Reported Functional Disability and Satisfaction in 2 Single‐Attack Phase 3 Randomized Trials, ACHIEVE I and II
- (2020) David W. Dodick et al. HEADACHE
- Influence of headache pain intensity and frequency on migraine-related disability in chronic migraine patients treated with OnabotulinumtoxinA
- (2020) Marta Torres-Ferrus et al. JOURNAL OF HEADACHE AND PAIN
- A bayesian approach to restricted latent class models for scientifically‐structured clustering of multivariate binary outcomes
- (2020) Zhenke Wu et al. BIOMETRICS
- Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition
- (2019) Hans-Christoph Diener et al. CEPHALALGIA
- Review of Acute Treatment of Migraine Trial Results With the New FDA Endpoints: Design Implications for Future Trials
- (2019) Nada A. Hindiyeh et al. HEADACHE
- Therapeutic novelties in migraine: new drugs, new hope?
- (2019) Thien Phu Do et al. JOURNAL OF HEADACHE AND PAIN
- Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine
- (2019) Richard B. Lipton et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Migraine progression in subgroups of migraine based on comorbidities
- (2019) Richard B. Lipton et al. NEUROLOGY
- Most Bothersome Symptom in Persons With Migraine: Results From the Migraine in America Symptoms and Treatment (MAST) Study
- (2019) Sagar Munjal et al. HEADACHE
- Mechanisms of migraine as a chronic evolutive condition
- (2019) Anna P. Andreou et al. JOURNAL OF HEADACHE AND PAIN
- Ubrogepant for the Treatment of Migraine
- (2019) David W. Dodick et al. NEW ENGLAND JOURNAL OF MEDICINE
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
- (2018) CEPHALALGIA
- Identifying Natural Subgroups of Migraine Based on Comorbidity and Concomitant Condition Profiles: Results of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
- (2018) Richard B. Lipton et al. HEADACHE
- The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice
- (2018) HEADACHE
- A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine
- (2016) Tiffini Voss et al. CEPHALALGIA
- Developmental trajectories of paediatric headache – sex-specific analyses and predictors
- (2016) Corinna Isensee et al. JOURNAL OF HEADACHE AND PAIN
- The Acute Treatment of Migraine in Adults: The American Headache Society Evidence Assessment of Migraine Pharmacotherapies
- (2015) Michael J. Marmura et al. HEADACHE
- Migraine: Multiple Processes, Complex Pathophysiology
- (2015) R. Burstein et al. JOURNAL OF NEUROSCIENCE
- Improving the Classification of Migraine Subtypes: An Empirical Approach Based on Factor Mixture Models in the American Migraine Prevalence and Prevention (AMPP) Study
- (2014) Richard B. Lipton et al. HEADACHE
- What Do Patients Consider to Be the Most Important Outcomes for Effectiveness Studies on Migraine Treatment? Results of a Delphi Study
- (2014) Antonia F. H. Smelt et al. PLoS One
- Consistency of Return to Normal Function, Productivity, and Satisfaction Following Migraine Attacks Treated With Sumatriptan/Naproxen Sodium Combination
- (2013) Stephen H. Landy et al. HEADACHE
- Pathophysiology of Migraine
- (2012) Daniela Pietrobon et al. Annual Review of Physiology
- Migraine symptomatology and major depressive disorder
- (2010) Lannie Ligthart et al. CEPHALALGIA
- Meeting patient expectations in migraine treatment: what are the key endpoints?
- (2008) Fabio Antonaci et al. JOURNAL OF HEADACHE AND PAIN
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started